BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8881094)

  • 1. Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability.
    Williams SL; Falbo J
    Behav Res Ther; 1996 Mar; 34(3):253-64. PubMed ID: 8881094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interoceptive exposure versus breathing retraining within cognitive-behavioural therapy for panic disorder with agoraphobia.
    Craske MG; Rowe M; Lewin M; Noriega-Dimitri R
    Br J Clin Psychol; 1997 Feb; 36(1):85-99. PubMed ID: 9051281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panic control treatment for agoraphobia.
    Craske MG; DeCola JP; Sachs AD; Pontillo DC
    J Anxiety Disord; 2003; 17(3):321-33. PubMed ID: 12727125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia.
    van den Hout M; Arntz A; Hoekstra R
    Behav Res Ther; 1994 May; 32(4):447-51. PubMed ID: 7910732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-monitoring of panic attacks and retrospective estimates of panic: discordant findings.
    de Beurs E; Lange A; Van Dyck R
    Behav Res Ther; 1992 Jul; 30(4):411-3. PubMed ID: 1352100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia.
    Bouchard S; Gauthier J; Laberge B; French D; Pelletier MH; Godbout C
    Behav Res Ther; 1996 Mar; 34(3):213-24. PubMed ID: 8881091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
    Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
    Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applied relaxation, exposure in vivo and cognitive methods in the treatment of panic disorder with agoraphobia.
    Ost LG; Westling BE; Hellström K
    Behav Res Ther; 1993 May; 31(4):383-94. PubMed ID: 8099789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.
    Noda Y; Nakano Y; Lee K; Ogawa S; Kinoshita Y; Funayama T; Watanabe N; Chen J; Noguchi Y; Kataoka M; Suzuki M; Furukawa TA
    BMC Psychiatry; 2007 Dec; 7():70. PubMed ID: 18067686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone.
    de Beurs E; van Balkom AJ; Lange A; Koele P; van Dyck R
    Am J Psychiatry; 1995 May; 152(5):683-91. PubMed ID: 7726307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory training prior to exposure in vivo in the treatment of panic disorder with agoraphobia: efficacy and predictors of outcome.
    de Beurs E; Lange A; van Dyck R; Koele P
    Aust N Z J Psychiatry; 1995 Mar; 29(1):104-13. PubMed ID: 7625959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments.
    van Balkom AJ; Bakker A; Spinhoven P; Blaauw BM; Smeenk S; Ruesink B
    J Nerv Ment Dis; 1997 Aug; 185(8):510-6. PubMed ID: 9284865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of personality disorders on response to cognitive behavioral therapy of panic disorder with agoraphobia].
    Marchand A; Wapler M
    Can J Psychiatry; 1993 Apr; 38(3):163-6. PubMed ID: 8500066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of panic disorder with agoraphobia treated by exposure.
    Fava GA; Rafanelli C; Grandi S; Conti S; Ruini C; Mangelli L; Belluardo P
    Psychol Med; 2001 Jul; 31(5):891-8. PubMed ID: 11459386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition-behaviour links in the persistence of panic.
    Salkovskis PM; Clark DM; Gelder MG
    Behav Res Ther; 1996; 34(5-6):453-8. PubMed ID: 8687367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
    Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P
    Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief treatment of emergency room patients with panic attacks.
    Swinson RP; Soulios C; Cox BJ; Kuch K
    Am J Psychiatry; 1992 Jul; 149(7):944-6. PubMed ID: 1351703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure.
    Başoğlu M; Marks IM; Swinson RP; Noshirvani H; O'Sullivan G; Kuch K
    J Affect Disord; 1994 Feb; 30(2):123-32. PubMed ID: 7911132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of different variables on the outcome of various cognitive-behavioral treatment modalities for panic disorder with agoraphobia].
    Marchand A; Germain V
    Encephale; 2004; 30(6):548-56. PubMed ID: 15738857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.